Macrogenics Inc (NAS:MGNX)
$ 4.36 0.25 (6.07%) Market Cap: 273.08 Mil Enterprise Value: 122.86 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 60/100

MacroGenics Inc at H.C. Wainwright BioConnect Investor Conference Transcript

May 02, 2023 / 05:00PM GMT
Release Date Price: $6.81 (-8.10%)
Robert Burns
H.C. Wainwright & Co. - Analyst

Thank you for joining our next fireside chat. I'm Robert Burns as Managing Director and Senior Biotech Analyst at H.C. Wainwright. I'm joined today by Scott Koenig, the CEO of MacroGenics. Scott, thank you for having (multiple speakers) --

Scott Koenig
MacroGenics, Inc. - President, CEO, and Director

It's our pleasure, Robert.

Robert Burns
H.C. Wainwright & Co. - Analyst

So why don't we just dive in? So for those who may be unfamiliar with MacroGenics and its pipeline, can you provide a brief high-level overview of the internal assets that you're developing, as well as what the near-term catalysts look like for MacroGenics?

Scott Koenig
MacroGenics, Inc. - President, CEO, and Director

Thank you very much, Robert. It's been 23 years since the start of the company. So I'm hoping some people are familiar with what we do.

We've been working on immune-based therapeutics, antibody-like structures since our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot